Search Videos by Topic or Participant
Browse by Series:

Splenectomy in Idiopathic Thrombocytopenic Purpura

Panelists: Howard A. Liebman, MD, USC; Keith McCrae, MD, Cleveland Clinic; Ivy Altomare, MD, Duke
Published: Friday, May 22, 2015
For High-Definition, Click
Determining the best candidates for surgical treatment of idiopathic thrombocytopenic purpura (ITP) is largely patient specific, says Howard A. Liebman, MD. Some patients opt for surgical intervention if they encounter difficulty taking medications. The response rates in younger women tends to be in the range of 65%, while individuals older than 50 years have lower response rates. Unfortunately, there is not a definitive way to predict who is going to respond, notes Liebman.

Laparoscopic splenectomy is generally a low-risk, but not a no-risk, procedure, says Ivy Altomare, MD. Perioperative mortality is approximately 1%, and infection, bleeding, and postoperative complications are estimated at 9% to 20%. Once a patient has had a splenectomy they have a long-term risk of sepsis, thrombosis, and atherosclerosism, Altomare warns. In general, a durable response is achieved in about two-thirds of patients.

Over the course of a 6-year study, only 7% of newly diagnosed patients had their spleens removed, Altomare notes. Key indications for a splenectomy would include poor response to steroids and other treatments and excessive bleeding for aggressive forms of ITP, notes Keith McCrae, MD.
Slider Left
Slider Right
For High-Definition, Click
Determining the best candidates for surgical treatment of idiopathic thrombocytopenic purpura (ITP) is largely patient specific, says Howard A. Liebman, MD. Some patients opt for surgical intervention if they encounter difficulty taking medications. The response rates in younger women tends to be in the range of 65%, while individuals older than 50 years have lower response rates. Unfortunately, there is not a definitive way to predict who is going to respond, notes Liebman.

Laparoscopic splenectomy is generally a low-risk, but not a no-risk, procedure, says Ivy Altomare, MD. Perioperative mortality is approximately 1%, and infection, bleeding, and postoperative complications are estimated at 9% to 20%. Once a patient has had a splenectomy they have a long-term risk of sepsis, thrombosis, and atherosclerosism, Altomare warns. In general, a durable response is achieved in about two-thirds of patients.

Over the course of a 6-year study, only 7% of newly diagnosed patients had their spleens removed, Altomare notes. Key indications for a splenectomy would include poor response to steroids and other treatments and excessive bleeding for aggressive forms of ITP, notes Keith McCrae, MD.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x